Skip to main content
ABBV logo
ABBV
(NYSE)
AbbVie Inc.
$209.41-- (--)
Loading... - Market loading

AbbVie (ABBV) Stock Price & Financial Analysis

AbbVie Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$207.68 - $211.36
52-Week High$244.81
52-Week Low$176.57
Open$210.37
Volume4.75M
Average Volume (3M)6.50M
Market Cap373.23B
Shares Outstanding1.77B
P/E Ratio (TTM)102.68
Forward P/E117.86
Price to Sales (P/S)5.94
Price to Book (P/B)-115.62
EV/EBITDA21.19
Revenue (TTM)62.82B
Net Income (TTM)3.63B
Free Cash Flow (TTM)17.82B
EPS (TTM)$2.05
Profit Margin5.79%
Operating Margin26.42%
50-Day MA$211.21
200-Day MA$218.48
52-Week Change6.69%
Annual Dividend$6.74
Dividend Yield3.22%
Payout Ratio200.00%
Last Dividend Ex-DateApr 15, 2026

Frequently Asked Questions About AbbVie

What is the current stock price for ABBV?

As of the latest trading session, ABBV stock trades at $209.41. The 52-week range is $176.57–$244.81, with a day range of $207.68–$211.36.

What is the P/E ratio for ABBV?

AbbVie's trailing P/E ratio is 102.7, meaning investors pay $102.7 for every $1 of annual earnings. The forward P/E is 117.9, reflecting analyst expectations for future earnings.

Does ABBV pay dividends?

Yes, AbbVie pays a 3.22% annual dividend yield ($6.74 per share). The payout ratio is 200.0%. The last ex-dividend date was 2026-04-15.

What do analysts recommend for ABBV?

Based on 20 analysts, the consensus for ABBV is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of ABBV?

AbbVie's market capitalization is $371.49B, classifying it as a mega-cap company..